Fig. 5From: Fructo-oligosaccharides ameliorate steatohepatitis, visceral adiposity, and associated chronic inflammation via increased production of short-chain fatty acids in a mouse model of non-alcoholic steatohepatitisFecal and serum SCFA concentrations in the control, MSG, and MSG + FOS mice at 18 weeks. *p < 0.05, **p < 0.01. FOS, fructo-oligosaccharides; MSG, monosodium glutamate; SCFA, short-chain fatty acidsBack to article page